tirzepatide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42372355
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model.
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model.
- 저자
- Yuxuan Liu, Xiaojun Liu
- 저널
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1016/j.biopha.2026.119717
문헌 요약
Metabolic diseases such as obesity and type 2 diabetes are complex disorders involving multiple dysregulated pathways, which may limit the efficacy of single-target therapies. To address this challenge, we developed a trispecific peptibody integrating glucagon-like peptide-1 receptor (GLP-1R) agonism, glucose-dependent insulinotropic polypeptide receptor…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.